Systematic review of the efficacy, effectiveness and safety of high‐dose seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age
Laura Comber(Health and Safety Authority), Patricia Harrington(Health and Safety Authority), Marta Soler Soneira(Instituto de Salud Carlos III), AnnaSara Carnahan(Swedish Institute), Ole Wichmann(Robert Koch Institute), Éamon Ó Murchú(Trinity College Dublin), Conor Teljeur(Health and Safety Authority), Ioanna D. Pavlopoulou(National and Kapodistrian University of Athens), Pasi Penttinen(European Centre for Disease Prevention and Control), Hanna Nohynek(Finnish Institute for Health and Welfare), Tyra Grove Krause(Statens Serum Institut), Nathalie Nicolay(European Centre for Disease Prevention and Control), Jaime Jesús Pérez Martín(Servicio Murciano de Salud), Karen Jordan(Health and Safety Authority), Máirín Ryan(University College Dublin), Richard Pebody(National Security Agency), Jørgen de Jonge(National Institute for Public Health and the Environment), Kari Johansen(European Centre for Disease Prevention and Control), Michelle O’Neill(Health and Safety Authority), Sarah Hawkshaw(Health and Safety Authority), Liam E. Marshall(Northwood University), Anna Hayman Robertson(Norwegian Institute of Public Health)
Cited by 44
Related Papers
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
Neurological complications of dengue virus infection
|The Lancet Neurology|2013|500
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies
|PLoS Medicine|2022|298
Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021
|Eurosurveillance|2021|281
Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort
|International Journal of Epidemiology|2020|280